Hepatitis delta virus and the host response: current status and future perspectives.

H. C. Thomas, P. Karayiannis, J. Monjardino, A. McNair

Research output: Contribution to journalReview article

Abstract

The demonstration that recombinant vaccinia can control the level of viraemia after HDV superinfection raises the possibility that established HBV carriers can be immunized against HDV. Furthermore the likelihood that this protective effect is dependent on the induction of a CTL response to HDV raises the possibility that the therapeutic effect of interferon operates by the induction of this cellular response. The failure of interferon to exert a direct inhibitory effect on HDV replication needs further investigation as does the nature of the immune responses involved in the protective effect induced by immunization with recombinant vaccinia.

Original languageEnglish
Pages (from-to)431-435
Number of pages5
JournalProgress in clinical and biological research
Volume382
Publication statusPublished - 1993

Fingerprint Dive into the research topics of 'Hepatitis delta virus and the host response: current status and future perspectives.'. Together they form a unique fingerprint.

  • Cite this